CWS Performance — AdvisorShares Focused Equity ETF
Data updated: 2026-09-10
CWS returned −0.61% year to date and −2.16% over one year to Jun 2026. Annualised returns are +8.77% over 3 years and +8.30% over 5 years. The fund trailed its US Mid-Cap Blend category average: $100 invested three years ago grew to $129, against $150 for the category, and to $98 over one year, against $122. Volatility over the past three years was 14.63% a year. In the 12 months to Jun 2026 the fund lost a net $54.8M, and assets reached $132.40M.
CWS Growth of $100
What $100 invested in AdvisorShares Focused Equity ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Blend category average over the same months.
| Period | CWS | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $98 | $122 |
| 3 years (Jul 2023 – Jun 2026) | $129 | $150 |
| 5 years (Jul 2021 – Jun 2026) | $149 | $147 |
| Since data start (Jul 2019 – Jun 2026) | $203 | $208 |
CWS Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −0.61% |
| 1 year | −2.16% |
| 3 years (annualised) | +8.77% |
| 5 years (annualised) | +8.30% |
CWS Annual Returns
Calendar-year total returns of AdvisorShares Focused Equity ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | −0.61% |
| 2025 | +6.31% |
| 2024 | +10.18% |
| 2023 | +25.25% |
| 2022 | −9.53% |
| 2021 | +21.31% |
| 2020 | +16.90% |
| 2019 (Jul–Dec) | +8.64% |
CWS Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0% | +1.8% | −7.2% | +5.8% | −1.5% | +1.1% | — | — | — | — | — | — |
| 2025 | +4.8% | −1.0% | −2.6% | −0.6% | +5.0% | +2.3% | −1.6% | +0.2% | −0.5% | −2.1% | +2.9% | −0.4% |
| 2024 | +1.2% | +2.8% | +3.1% | −4.5% | +3.3% | −0.7% | +6.4% | +2.5% | +1.3% | −1.9% | +5.9% | −8.8% |
| 2023 | +7.3% | −2.4% | +2.2% | +0.1% | −3.7% | +9.9% | +3.5% | −0.9% | −5.5% | −5.0% | +11.8% | +7.3% |
| 2022 | −7.2% | −2.9% | +1.3% | −5.8% | −0.9% | −5.7% | +9.4% | −3.7% | −7.5% | +10.2% | +8.1% | −2.9% |
| 2021 | −2.3% | +0.3% | +4.7% | +5.5% | −1.0% | +0.3% | +3.4% | +1.4% | −5.2% | +6.7% | −0.6% | +7.2% |
| 2020 | +1.0% | −9.0% | −10.7% | +10.7% | +5.8% | −0.4% | +8.5% | +3.1% | −2.4% | −2.1% | +9.2% | +4.6% |
| 2019 | — | — | — | — | — | — | +1.9% | 0.0% | +0.2% | +1.0% | +4.1% | +1.1% |
CWS Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 14.63%
- 3-year Sharpe ratio: 0.29 (vs 4.5% risk-free rate)
- Best month: +11.82% (Nov 2023)
- Worst month: −8.78% (Dec 2024)
CWS Fund Flows
Monthly money in and out of AdvisorShares Focused Equity ETF, from SEC Form N-PORT.
- 12-month net flow: −$54.8M
- 12-month gross sales (incl. reinvestments): $1.7M
- Sales ÷ redemptions: 0.03×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $0 | $2.4M | −$2.4M |
| May 2026 | $0 | $19.5M | −$19.5M |
| Apr 2026 | $0 | $7.7M | −$7.7M |
| Mar 2026 | $0 | $5.1M | −$5.1M |
| Feb 2026 | $0 | $6.6M | −$6.6M |
| Jan 2026 | $0 | $3.9M | −$3.9M |
| Dec 2025 | $0 | $3.5M | −$3.5M |
| Nov 2025 | $1.0M | $690K | $324K |
| Oct 2025 | $0 | $4.1M | −$4.1M |
| Sep 2025 | $0 | $3.1M | −$3.1M |
| Aug 2025 | $687K | $0 | $687K |
| Jul 2025 | $0 | $0 | $0 |
CWS Assets Under Management
Net assets of AdvisorShares Focused Equity ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $132.40M |
| 2026-03-31 | $154.25M |
| 2025-12-31 | $179.23M |
| 2025-09-30 | $186.41M |
| 2025-06-30 | $192.42M |
| 2025-03-31 | $175.77M |
| 2024-12-31 | $175.58M |
| 2024-09-30 | $173.17M |
| 2024-06-28 | $154.19M |
| 2024-03-28 | $146.62M |
| 2023-12-29 | $86.36M |
| 2023-09-29 | $72.07M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.